pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,730 catalysts · 5,159 phase readout · 2,286 8k filing · 315 pdufa · 256 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 14 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: earnings×type: phase readout×type: pdufa×clear all
type
  • phase readout5,159
  • 8k filing2,286
  • pdufa315
  • earnings256
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›NOT_YET_RECRUITINGphase readoutNCT07626164: Three Photobiomodulation Wavelengths (635, 940, and 1064 nm) on Chronic Myogenic Temporomandibular Disorder

Sponsor: Alexandria University. Phase: NA. Conditions: Temporomandibular Disorders

full page →ctgov ↗
›WITHDRAWNphase readoutNCT06103734: A Study to Learn About Zavegepant as a Treatment for Multiple Migraine Attacks in Adult Participants

Sponsor: Pfizer. Phase: PHASE3. Conditions: Migraine

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06768034: SecondarY Prevention and maNagement of Myocardial Injury aftER Noncardiac surGerY (SYNERGY) Pilot Trial

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM). Phase: NA. Conditions: Myocardial Injury After Noncardiac Surgery (MINS)

full page →ctgov ↗
›COMPLETEDphase readoutNCT06055309: Behavioral Pharmacology of Cannabis in Older Adults

Sponsor: University of Arkansas. Phase: PHASE1. Conditions: Health Services for the Aged

full page →ctgov ↗
›RECRUITINGphase readoutNCT05367609: Personalized Perioperative Analgesia Platform (PPAP) for Pediatric Spine Fusion Surgery (sIRB)

Sponsor: Senthil Sadhasivam. Phase: NA. Conditions: PPAP, Spine Fusion

full page →ctgov ↗
›COMPLETEDphase readoutNCT04418999: Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus

Sponsor: Illinois College of Optometry. Phase: EARLY_PHASE1. Conditions: Keratoconus, Dry Eye, Allergy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07281599: Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer

Sponsor: Qurasense. Phase: NA. Conditions: HPV Infection, HPV 16 Infection, High Risk HPV, Cervical Cancer Screening, Cervical Cancer Cin Grade, Cervical Cancer (Early Detection), HPV, HPV (Human Papillomavirus)-Associated, HPV DNA, HPV Infections, Screening Test

full page →ctgov ↗
›RECRUITINGphase readoutNCT04290663: Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up

Sponsor: Centre Francois Baclesse. Phase: PHASE3. Conditions: Thyroid Cancer, Intermediate Risk

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07627893: Complementary Herbal Approach to Rheumatoid Management Study (CHARMS)

Sponsor: Singapore General Hospital. Phase: PHASE2. Conditions: Rheumatoid Arthritis (RA)

full page →ctgov ↗
›COMPLETEDphase readoutNCT06812793: Muscle Endurance in Children With Cystic Fibrosis

Sponsor: Bezmialem Vakif University. Phase: . Conditions: Cystic Fibrosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT05321121: Dexmedotomidine for Acute Pain Control in Patients With Multiple Rib FracturesRandomized Controlled Trial

Sponsor: University of California, Irvine. Phase: PHASE4. Conditions: Rib Fractures, Pain, Acute

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05911321: Isa-Pom-Dex in Elderly/Frail Subjects With RRMM

Sponsor: UNC Lineberger Comprehensive Cancer Center. Phase: PHASE2. Conditions: Multiple Myeloma, Relapse, Refractory, Aging, Co-morbidity

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05946993: Linking In With Advice and Supports for Men Impacted by Metastatic Cancer

Sponsor: University College Cork. Phase: NA. Conditions: Survivorship, Prostate Cancer, Kidney Cancer, Urothelial Tract/Bladder Cancer, Nos, Testicular Cancer, Penile Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT02061306: Celiac Disease Genomic Environmental Microbiome and Metabolomic Study

Sponsor: Massachusetts General Hospital. Phase: . Conditions: Celiac Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT06492304: A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies

Sponsor: CRISPR Therapeutics. Phase: PHASE1. Conditions: T Cell Lymphoma, B Cell Lymphoma, Acute Myeloid Leukemia

full page →ctgov ↗
›COMPLETEDphase readoutNCT07471204: Evaluation of Muscle Oxygenation and Recovery Dynamics in Individuals With Knee Osteoarthritis

Sponsor: Bahçeşehir University. Phase: . Conditions: Osteoarthritis of Knee, Healthy Participants

full page →ctgov ↗
›COMPLETEDphase readoutNCT03854552: A Study in Healthy Men Tests How Different Doses of BI 764198 Are Taken up in the Body and How Well They Are Tolerated.

Sponsor: Boehringer Ingelheim. Phase: PHASE1. Conditions: Healthy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07410949: Postpartum Acupressure Education and Breastfeeding Outcomes

Sponsor: Nigde Omer Halisdemir University. Phase: NA. Conditions: Breastfeeding, Lactation, Postpartum Period

full page →ctgov ↗
›RECRUITINGphase readoutNCT06463158: The Impact of the Family Room App on Caregivers

Sponsor: University of Nebraska. Phase: NA. Conditions: Well-Being, Psychological, Engagement, Satisfaction, Consumer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07468955: Impact of Cardiac Rehabilitation on Patient Outcomes

Sponsor: Kutahya Health Sciences University. Phase: NA. Conditions: Coronary Artery Disease, Coronary Heart Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT00605878: Studies of Skin Microbes in Healthy People and in People With Skin Conditions

Sponsor: National Human Genome Research Institute (NHGRI). Phase: . Conditions: Eczema, Atopic Dermatitis

full page →ctgov ↗
›COMPLETEDphase readoutNCT06927115: Comparative Analysis of Mulligan and Maitland Mobilizations Techniques in Adhesive Capsulitis

Sponsor: Riphah International University. Phase: NA. Conditions: Adhesive Capsulitis of Shoulder

full page →ctgov ↗
›RECRUITINGphase readoutNCT04391335: Novel Pulmonary Function Measures for Diagnosis of Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem-Cell Transplantation in Children

Sponsor: The Hospital for Sick Children. Phase: . Conditions: Bronchiolitis Obliterans Syndrome

full page →ctgov ↗
›COMPLETEDphase readoutNCT00083135: N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation

Sponsor: New Approaches to Neuroblastoma Therapy Consortium. Phase: PHASE1. Conditions: Neuroblastoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02710435: REDUCER-I: An Observational Study of the Neovasc Reducer™ System

Sponsor: Shockwave Medical, Inc.. Phase: . Conditions: Angina Pectoris, Angina Pectoris, Stable, Chronic Stable Angina

full page →ctgov ↗
›RECRUITINGphase readoutNCT06784908: Stress and Pain in People Living With HIV

Sponsor: Yale University. Phase: NA. Conditions: HIV, Depression, Cannabis Use Disorder, Stress, Pain

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07263776: Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Anterior Circulation Large Vessel Occlusion Stroke -2

Sponsor: Capital Medical University. Phase: PHASE3. Conditions: Acute Ischemic Stroke

full page →ctgov ↗
›RECRUITINGphase readoutNCT07398417: Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

Sponsor: Axsome Therapeutics, Inc.. Phase: PHASE3. Conditions: Fibromyalgia

full page →ctgov ↗
›COMPLETEDphase readoutNCT05520840: Evaluation of Peripheral Blood Protein Biomarkers for Colorectal Cancer Screening

Sponsor: University Hospital, Rouen. Phase: NA. Conditions: Colorectal Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05508789: A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)

Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Tauopathies, Neurodegenerative Diseases, Neurocognitive Disorders, Mental Disorders

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07404293: Zero CDE Technique for Lens Removal During FLACS

Sponsor: Bochner Eye Institute. Phase: NA. Conditions: Cataract With a Nuclear Sclerosis Grade Between 1 to 3

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07359521: Implementation and Evaluation of a Complex Intervention to Reduce Avoidable Transitions Between Nursing Home and Hospital

Sponsor: Vrije Universiteit Brussel. Phase: NA. Conditions: Potentially Avoidable Hospitalisations

full page →ctgov ↗
›COMPLETEDphase readoutNCT05097521: Assessing Pain, Patient Reported Outcomes and Complementary and Integrative Health

Sponsor: VA Office of Research and Development. Phase: . Conditions: Chronic Musculoskeletal Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT05723614: TRUsted rEsidents and Housing Assistance to Decrease Violence Exposure in New Haven

Sponsor: Yale University. Phase: NA. Conditions: Firearm Injury

full page →ctgov ↗
›COMPLETEDphase readoutNCT04298606: A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence

Sponsor: Roswell Park Cancer Institute. Phase: EARLY_PHASE1. Conditions: Chronic Obstructive Pulmonary Disease, Lung Non-Small Cell Carcinoma, Pneumonia, Stage IB Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8, Stage IIB Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8

full page →ctgov ↗
›COMPLETEDphase readoutNCT04984733: Temozolomide + Nivolumab in MGMT Methylated Oesophagogastric Cancer

Sponsor: University of Southampton. Phase: PHASE2. Conditions: Adenocarcinoma - GEJ, Cancer of Esophagus

full page →ctgov ↗
›COMPLETEDphase readoutNCT07582952: Effect of Meal Frequency on Diet Self-Efficacy and Perceived Stress in Women With Weight Cycling

Sponsor: Ankara Medipol University. Phase: NA. Conditions: Weight Cycling, Obesity & Overweight, Dietary Self-efficiacy, Perceived Stress, Meal Frequency

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07568847: Improving Hospital-To-Methadone Clinic Connection Using Implementation Support for Patients With Opioid Use Disorder

Sponsor: University of Colorado, Denver. Phase: NA. Conditions: Opioid Use Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT07616349: Prediction of Platelet Function Using Viscoelastic Test (ROTEM® Sigma) in Obstetric Anesthesia.

Sponsor: Nicolas Brogly. Phase: . Conditions: Thrombocytopenia, Postpartum Haemorrhage (PPH)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07321249: Is There an Association Between Smartsphone Addiction and Obesity in Young Adults?

Sponsor: Alaa Mohamed Naguib Ashry. Phase: . Conditions: Obesity

full page →ctgov ↗
›RECRUITINGphase readoutNCT07631338: Low-grade Gliomas in Argentina: Incidence, Survival, and Therapeutic Strategies

Sponsor: Hospital Italiano de Buenos Aires. Phase: . Conditions: Low-grade Glioma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06657248: Clinical Performance and Safety of the Unicompartmental Univation® XF Pro Implant

Sponsor: Aesculap AG. Phase: . Conditions: Gonarthritis, Degenerative Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT05875155: Ovarian Tissue Cryopreservation for Fertility Preservation

Sponsor: University of Pittsburgh. Phase: . Conditions: Cancer, Autoimmune Diseases

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06416878: Brief ES for Recovery of Autonomic Function in CES

Sponsor: University of Liverpool. Phase: NA. Conditions: Cauda Equina Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT07574385: Sciatic Nerve Block With ALX006 in Subjects Undergoing Bunionectomy

Sponsor: Rebel Medicine Inc. Phase: PHASE2. Conditions: Hallux Valgus, Bunionectomy

full page →ctgov ↗
›COMPLETEDphase readoutNCT07462585: Impact of the Model Health Behaviour Mother 1000 Days of Life Health Online-Based on Prenatal, Intranatal, and Postnatal

Sponsor: Siti Saidah Nasution. Phase: NA. Conditions: Pregnancy

full page →ctgov ↗
›TERMINATEDphase readoutNCT04643535: In Vivo Glycocalyx as Predictor of Complications After Cardiac Surgery

Sponsor: University Hospital, Rouen. Phase: . Conditions: Endothelial Dysfunction, Cardiovascular Diseases, Surgery

full page →ctgov ↗
›TERMINATEDphase readoutNCT02961335: Validation of Alveolar Probe-based Confocal Laser Endomicroscopy Descriptors in Diffuse Parenchymal Lung Diseases

Sponsor: University Hospital, Rouen. Phase: NA. Conditions: Diffuse Parenchymal Lung Diseases

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07528235: An Open-Label, Dose-Escalation Study on the Safety, Tolerability and Preliminary Efficacy for Preventing SAP by Intravenous Pump-Delivered Propranolol in Patients With ICH

Sponsor: Tang-Du Hospital. Phase: PHASE1. Conditions: Intracerebral Hemorrhage, Stroke-Associated Pneumonia (SAP)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07487935: Determinants of Clinical Outcome After Caudal Epidural Adhesiolysis for Chronic Lumbar Radicular Pain

Sponsor: Mersin University. Phase: . Conditions: Radicular Pain, Adhesiolysis, Disc Disease Lumbar

full page →ctgov ↗
← prev
page 84 of 115
next →